Synabs

In order to overtake the limitations of mouse model with difficult immunogens, SynAbs has been founded at the end of 2015, in Belgium, based on the work of Pr. Bazin. SYnAbs is offering unique multi-species immunization approach (proprietary rat and guinea pig myeloma cell lines), combined with particular immunization schemes to generate an extensive catalog of off-the-shelf secondary monoclonal antibodies for your R&D applications, targeting multiple repertoires :

• anti–mouse monoclonal antibodies
• anti-rat monoclonal antibodies
• anti-human monoclonal antibodies
• anti-rabbit monoclonal antibodies
• anti-species monoclonal antibodies : anti-pig, anti-horse, anti-chicken, anti-baboon, anti-bullock, anti-dog and anti-rabbit mAbs.